Hospital de Clínicas de Porto Alegre
Hospital de Clínicas de Porto Alegre
Santa Cecília, Porto Alegre - RS, 90450-190, Brazil
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Beatriz D'agord Schaan
Open studies
Breast Cancer
Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction - SCHOLAR-2 - Population Health Research InstituteSee more
Cytomegalovirus
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT) - Takeda Development Center Americas, Inc.See more
Ectopic Pregnancy
Fibromyalgia
Cortical Excitability Modulation With ctDCS in Fibromyalgia. - ctDCS - Hospital de Clinicas de Porto AlegreSee more
Heart failure
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation - HERMES - Novo Nordisk A/SSee more
Inflammation
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation - HERMES - Novo Nordisk A/SSee more
Lupus
A Study to Assess the Efficacy and Safety of BIIB059 (Litifilimab) in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy - AMETHYST - BiogenSee more
Multiple myeloma
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide - MonumenTAL-6 - Janssen Research & Development, LLCSee more
Pneumonia
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) - ESsCAPE - BiotestSee more
Solid tumors
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors - Hoffmann-La RocheSee more
